Clinical Trials Logo

Clinical Trial Summary

Facioscapulohumeral Muscular Dystrophy (FSHD) is one of the most frequent muscular dystrophies in the adulthood. Multi-spectral optoacoustic tomography (MSOT) is an innovative imaging technique able to non-invasively characterize the molecular composition of the muscle tissue. With this pilot study we will explore the performance of MSOT imaging in FSHD patients and correlate the findings with clinical and MRI data, with the final aim to identify new disease biomarkers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05902884
Study type Interventional
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact Mauro Monforte
Phone +390630154155
Email mauro.monforte@policlinicogemelli.it
Status Recruiting
Phase N/A
Start date June 26, 2023
Completion date December 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05409079 - Schulze Muscular Dystrophy Ability Clinical Study N/A
Recruiting NCT05272969 - Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease
Recruiting NCT04635891 - Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Recruiting NCT05747924 - Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) Phase 1/Phase 2